Target intelligence / Profile preview

V-Myb myeloblastosis viral oncogene homolog (avian)-like 2 pseudogene

Molecular classification
Pseudogene, Other
01

Overview

The **V-Myb myeloblastosis viral oncogene homolog (avian)-like 2 pseudogene (ENSG00000250997)** is a genomic region classified as a pseudogene of the MYBL2 gene, and does not encode a functional protein. Pseudogenes are typically inactive remnants of genes that may arise by duplication or retrotransposition, lacking the necessary regulatory elements for transcription and translation[2][4]. Unlike functional MYBL2, which is a transcription factor involved in cell cycle regulation and proliferation, this pseudogene is not considered to have significant biological function or disease relevance. It is not a therapeutic target and is not implicated in pharmacological modulation or used for biomarker analysis[3][4].

Other names
MYBL2 pseudogenev-myb myeloblastosis viral oncogene homolog-like 2 pseudogeneV-Myb myeloblastosis viral oncogene homolog (avian)-like 2 pseudogene
02

Biological functions

Other (Pseudogenes generally do not have active biological functions; some may affect gene regulation through RNA, but this is rare and not established for ENSG00000250997 specifically)
03

Disease associations

Other (No direct established role in disease for this pseudogene; related functional genes, such as MYBL2/c-Myb, are implicated in cancer, but not the pseudogene form)

Beyond the preview

Go deeper on V-Myb myeloblastosis viral oncogene homolog (avian)-like 2 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on V-Myb myeloblastosis viral oncogene homolog (avian)-like 2 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call